U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Search Results

Somatropin Injection
Status: Currently in Shortage
»Date first posted: 01/06/2023
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Eli Lilly and Co. (Reverified 05/17/2024)

Company Contact Information:
800-545-5979

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Humatrope, Injection, 12 mg/vial (NDC 0002-8148-01) Available
Humatrope, Injection, 24 mg/vial (NDC 0002-8149-01) Available

Genentech, Inc (Revised 03/22/2024)

Company Contact Information:
800-551-2231

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Nutropin Aq, Injection, 10 mg/2 mL (NDC 50242-074-01) Limited Availability

Link to Discontinuation

Discontinuation of the manufacture of the drug
Nutropin Aq, Injection, 5 mg/2 mL (NDC 50242-075-01) Limited Availability

Link to Discontinuation

Discontinuation of the manufacture of the drug
Nutropin Aq, Injection, 20 mg/2 mL (NDC 50242-076-01) Limited Availability

Link to Discontinuation

Discontinuation of the manufacture of the drug

Novo Nordisk, Inc. (Reverified 04/30/2024)

Company Contact Information:
609-987-5800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Norditropin, Injection, 5 mg/1.5 mL (NDC 0169-7704-21) Limited Availability Intermittent supply until end of Q2 2024 Delay in shipping of the drug
Norditropin, Injection, 10 mg/1.5 mL (NDC 0169-7705-21) Available
Norditropin, Injection, 15 mg/1.5 mL (NDC 0169-7708-21) Available
Norditropin, Injection, 30 mg/3 mL (NDC 0169-7703-21) Unavailable Unavailable until end of 2024 Delay in shipping of the drug

Pfizer Inc. (Revised 05/24/2024)

Company Contact Information:
800-533-4535

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Genotropin, Injection, 5 mg/mL, w/ preservative (NDC 0013-2626-81) Available
Genotropin, Injection, 12 mg/mL, w/ preservative (NDC 0013-2646-81) Available
Genotropin, Injection, 0.2 mg preservative free (NDC 0013-2649-02) Available
Genotropin, Injection, 0.4 mg preservative free (NDC 0013-2650-02) Unavailable Next Delivery: June 2024; Estimated Recovery: late Q3 2024 Demand increase for the drug
Genotropin, Injection, 0.6 mg preservative free (NDC 0013-2651-02) Available
Genotropin, Injection, 0.8 mg preservative free (NDC 0013-2652-02) Available
Genotropin, Injection, 1.0 mg preservative free (NDC 0013-2653-02) Available
Genotropin, Injection, 1.2 mg preservative free (NDC 0013-2654-02) Available
Genotropin, Injection, 1.4 mg preservative free (NDC 0013-2655-02) Available
Genotropin, Injection, 1.6 mg preservative free (NDC 0013-2656-02) Available
Genotropin, Injection, 1.8 mg preservative free (NDC 0013-2657-02) Available
Genotropin, Injection, 2.0 mg preservative free (NDC 0013-2658-02) Available

Sandoz Inc. (Revised 05/30/2024)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Omnitrope, Injection, 5 mg/1.5 mL (NDC 0781-3001-07) Available
Omnitrope, Injection, 10 mg/1.5 mL (NDC 0781-3004-07) Available
Back to Top